Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients
Open Access
- 12 March 2009
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 113 (11) , 2442-2450
- https://doi.org/10.1182/blood-2008-05-157222
Abstract
Treatment of Epstein-Barr virus (EBV)–positive nasopharyngeal carcinoma (NPC) with EBV-specific cytotoxic T cells (EBV-specific CTL) has been promising, produciThis publication has 49 references indexed in Scilit:
- Regulatory T cells and tumour immunity – observations in mice and menImmunology, 2007
- Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transferBlood, 2007
- Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytesBlood, 2007
- Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 geneBlood, 2007
- Inability to Mediate Prolonged Reduction of Regulatory T Cells After Transfer of Autologous CD25-depleted PBMC and Interleukin-2 After Lymphodepleting ChemotherapyJournal of Immunotherapy, 2007
- Persistence of Tumor Infiltrating Lymphocytes in Adoptive Immunotherapy Correlates With Telomere LengthJournal of Immunotherapy, 2007
- Contact-activated Monocytes: Efficient Antigen Presenting Cells for the Stimulation of Antigen-specific T cellsJournal of Immunotherapy, 2007
- Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cellsJournal of Clinical Investigation, 2005
- Regulation of mature T cell homeostasisSeminars in Immunology, 2005
- Role of Cytotoxic T Lymphocytes in Epstein-Barr Virus-Associated DiseasesAnnual Review of Microbiology, 2000